Guidelines for the prevention of intravascular catheter-related infections

Clinical Infectious Diseases

Volumn 35, Issue 11, 2002, Pages 1281-1307

  O'Grady, Naomi P ^a   Alexander, Mary ^b   Dellinger, E Patchen ^e   Gerberding, Julie L ^f   Heard, Stephen O ^c   Maki, Dennis G ^h   Masur, Henry ^a   McCormick, Rita D ⁱ   Mermel, Leonard A ^j   Pearson, Michele L ^g   Raad, Issam I ^k   Randolph, Adrienne ^d   Weinstein, Robert A ^l  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Infusion Nurses Society   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^h UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

ⁱ University of Wisconsin Health   (United States)

^j BROWN UNIVERSITY   (United States)

^k UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^l Jr Hospital of Cook County   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZALKONIUM CHLORIDE; CHLORHEXIDINE GLUCONATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MINOCYCLINE; PLATINUM; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; SULFADIAZINE SILVER; VANCOMYCIN;

ANTIBIOTIC THERAPY; ANTISEPSIS; CATHETER INFECTION; CLINICAL TRIAL; HEALTH EDUCATION; HEMODIALYSIS; HEMODYNAMIC MONITORING; HOSPITAL INFECTION; HUMAN; HYGIENE; INCIDENCE; INFECTION PREVENTION; INTENSIVE CARE; INTRAVASCULAR CATHETER; MEDICAL INFORMATION; MEDICAL SOCIETY; META ANALYSIS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENESIS; PERIPHERAL VEIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY ARTERY; QUALITY CONTROL; REVIEW; RISK FACTOR; TECHNIQUE; UMBILICUS; UNITED STATES;

EID: 0036904779     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/344188     Document Type: Review

References (293)

1. Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: An overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24:262-77.
2. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391-402.
3. CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26:522-33.
4. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-81.
5. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162:1027-30.
6. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: A matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20:396-401.
7. Collignon PJ. Intravascular catheter associated sepsis: A common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994; 161:374-8.
8. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
9. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001; 136:229-34.
10. Mermel LA. Correction: Catheter related bloodstream-infections. Ann Intern Med 2000; 133:395.
11. Kluger DM, Maki DG. The relative risk of intravascular device related bloodstream infections in adults [abstract 1913]. In: Programs and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: American Society for Microbiology, 1999:514.
12. CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27:520-32.
13. Joint Commission on the Accreditation of Healthcare Organizations. Accreditation manual for hospitals. In: Joint Commission on the Accreditation of Healthcare Organizations, ed. Chicago, IL: Joint Commission on the Accreditation of Healthcare Organizations, 1994:121-40.
14. CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001; 6:404-21.
15. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91(Suppl 3B):S72-S75.
16. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91(Suppl):S86-S89.
17. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 31:327-32.
18. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 30:121-9.
19. Nguyen MH, Peacock JE Jr., Morris AJ, et al. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100:617-23.
20. Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med 1999; 20:303-16.
21. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296:1305-9.
22. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping. Am J Med 1991; 91(Suppl 3B):S197-S205.
23. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr 1985; 9:322-5.
24. Linares J, Sitges-Serra A, Garau J, Perez JL, Martin R. Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 1985; 21:357-60.
25. Raad II, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168:400-7.
26. Maki DG. Infections associated with intravascular lines. In: Remington JS, ed. Current Clinical Topics in Infectious Diseases. New York: McGraw-Hill, 1982:309-63.
27. Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 1983; 18:1061-3.
28. Ashkenazi S, Weiss E, Drucker MM, Bodey GP. Bacterial adherence to intravenous catheters and needles and its influence by cannula type and bacterial surface hydrophobicity. J Lab Clin Med 1986; 107:136-40.
29. Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices. IV. Scanning electron microscopy of intravenous catheters invaded by yeasts. Zentralbl Bakteriol Mikrobiol Hyg [B] 1981; 173:419-24.
30. Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices. I. Microtopographical characteristics of intravenous catheters as detected by scanning electron microscopy. Zentralbl Bakteriol Mikrobiol Hyg [B] 1981; 173:285-92.
31. Nachnani GH, Lessin LS, Motomiya T, Jensen WN, Bodey GP. Scanning electron microscopy of thrombogenesis on vascular catheter surfaces. N Engl J Med 1972; 286:139-40.
32. Stillman RM, Soliman F, Garcia L, Sawyer PN. Etiology of catheter-associated sepsis. Correlation with thrombogenicity. Arch Surg 1977; 112:1497-9.
33. Herrmann M, Lai QJ, Albrecht RM, Mosher DF, Proctor RA. Adhesion of Staphylococcus aureus to surface-bound platelets: Role of fibrinogen/fibrin and platelet integrins. J Infect Dis 1993; 167:312-22.
34. Herrmann M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 1991; 59:279-88.
35. Ludwicka A, Uhlenbruck G, Peters G, et al. Investigation on extracellular slime substance produced by Staphylococcus epidermidis. Zentralbl Bakteriol Mikrobiol Hyg 1984; 258:256-67.
36. Gray ED, Peters G, Verstegen M, Regelmann WE. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1984; 1:365-7.
37. Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis 1990; 161:37-40.
38. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32:452-6.
39. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000; 132:641-8.
40. Ryan JA Jr., Abel RM, Abbott WM, et al. Catheter complications in total parenteral nutrition: A prospective study of 200 consecutive patients. N Engl J Med 1974; 290:757-61.
41. Sanders RA, Sheldon GF. Septic complications of total parenteral nutrition: A five year experience. Am J Surg 1976; 132:214-20.
42. Murphy LM, Lipman TO. Central venous catheter care in parenteral nutrition: A review. Parenter Enteral Nutr 1987; 11:190-201.
43. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355:1864-8.
44. Armstrong CW, Mayhall CG, Miller KB, et al. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis 1986; 154:808-16.
45. Nehme AE. Nutritional support of the hospitalized patient: The team concept. JAMA 1980; 243:1906-8.
46. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: A randomized controlled trial. Arch Intern Med 1998; 158:473-7.
47. Tomford JW, Hershey CO. The IV therapy team: Impact on patient care and costs of hospitalization. NITA 1985; 8:387-9.
48. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996; 17:150-8.
49. Bansmer G, Keith D, Tesluk H. Complications following use of indwelling catheters of inferior vena cava. JAMA 1958; 167:1606-11.
50. Crane C. Venous interruption of septic thrombophlebitis. N Engl J Med 1960; 262:947-51.
51. Indar R. The dangers of indwelling polyethelene cannulae in deep veins. Lancet 1959; 1:284-6.
52. Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Hospital Infections. 4th Ed. Philadelphia: Lippencott-Raven, 1998:689-724.
53. Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998; 158:81-7.
54. Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990; 28:2520-5.
55. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: Effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998; 19:842-5.
56. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 2000; 117:178-83.
57. Mian NZ, Bayly R, Schreck DM, Besserman EB, Richmand D. Incidence of deep venous thrombosis associated with femoral venous catheterization. Acad Emerg Med 1997; 4:1118-21.
58. Durbec O, Viviand X, Potie F, Vialet R, Albanese J, Martin C. A prospective evaluation of the use of femoral venous catheters in critically ill adults. Crit Care Med 1997; 25:1986-9.
59. Trottier SJ, Veremakis C, O'Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: Results from a prospective, randomized trial. Crit Care Med 1995; 23:52-9.
60. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: A randomized controlled trial. JAMA 2001; 286:700-7.
61. Venkataraman ST, Thompson AE, Orr RA. Femoral vascular catheterization in critically ill infants and children. Clin Pediatr (Phila) 1997; 36:311-9.
62. Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous femoral venous catheterizations: A prospective study of complications. J Pediatr 1989; 114:411-5.
63. Goldstein AM, Weber JM, Sheridan RL. Femoral venous access is safe in burned children: An analysis of 224 catheters. J Pediatr 1997; 130:442-6.
64. Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: A meta-analysis of the literature. Crit Care Med 1996; 24:2053-8.
65. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987; 258:2396-403.
66. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: A randomized controlled trial. Ann Intern Med 1991; 114:845-54.
67. Band JD, Maki DG. Steel needles used for intravenous therapy: Morbidity in patients with hematologic malignancy. Arch Intern Med 1980; 140:31-4.
68. Tully JL, Friedland GH, Baldini LM, Goldmann DA. Complications of intravenous therapy with steel needles and Teflon® catheters: A comparative study. Am J Med 1981; 70:702-6.
69. Pittet D, Hugonnet S, Harbath S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000; 356:1307-9.
70. Larson EL, Rackoff WR, Weiman M, et al. APIC guideline for hand-washing and hand antisepsis in health care settings. Am J Infect Control 1995; 23:251-69.
71. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15:231-8.
72. Clemence MA, Walker D, Farr BM. Central venous catheter practices: Results of a survey. Am J Infect Control 1995; 23:5-12.
73. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338:339-43.
74. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000; 31:1001-7.
75. Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: A prospective trial. Pediatr Infect Dis J 1995; 14:510-6.
76. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing: A meta-analysis of the infection risks. JAMA 1992; 267:2072-6.
77. Maki DG, Mermel LA, Klugar D, et al. The efficacy of a chlorhexidine impregnated sponge (Biopatch) for the prevention of intravascular catheter-related infection- a prospective randomized controlled multicenter study [abstract 143C]. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, Canada. American Society for Microbiology, 2000.
78. Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol 2002; 13:77-81.
79. Rusho WJ, Bair JN. Effect of filtration on complications of postoperative intravenous therapy. Am J Hosp Pharm 1979; 36:1355-6.
80. Maddox RR, John JF Jr., Brown LL, Smith CE. Effect of inline filtration on postinfusion phlebitis. Clin Pharm 1983; 2:58-61.
81. Turco SJ, Davis NM. Particulate matter in intravenous infusion fluids - Phase 3. Am J Hosp Pharm 1973; 30:611-3.
82. Baumgartner TG, Schmidt GL, Thakker KM, et al. Bacterial endotoxin retention by inline intravenous filters. Am J Hosp Pharm 1986; 43:681-4.
83. Butler DL, Munson JM, DeLuca PP. Effect of inline filtration on the potency of low-dose drugs. Am J Hosp Pharm 1980; 37:935-41.
84. Raad II, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127:267-74.
85. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis. JAMA 1999; 281:261-7.
86. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: A randomized, controlled trial. Ann Intern Med 1997; 127:257-66.
87. Raad II, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996; 173:418-24.
88. Bassetti S, Hu J, D'Agostino RB Jr., Sherertz RJ. Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother 2001; 45:1535-8.
89. Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology 1997; 87:1242-4.
90. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282:554-60.
91. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340:1-8.
92. Institute of Medicine. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press, 2000.
93. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial. Am J Med 1988; 85:307-14.
94. Dahlberg PJ, Agger WA, Singer JR, et al. Subclavian hemodialysis catheter infections: A prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 1995; 16:506-11.
95. Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 1993; 218:206-10.
96. Bonawitz SC, Hammell EJ, Kirkpatrick JR. Prevention of central venous catheter sepsis: A prospective randomized trial. Am Surg 1991; 57:618-23.
97. McKee R, Dunsmuir R, Whitby M, Garden OJ. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985; 6:419-25.
98. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15:95-102.
99. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: A randomized, controlled study. Support Care Cancer 1997; 5:485-8.
100. Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of gram-positive sepsis in neonates weighing less than 1500 g. J Pediatr 1994; 125:253-8.
101. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr 1994; 125:259-63.
102. CDC. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1995; 44(RR-12):1-20.
103. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991; 40:934-8.
104. Casewell MW. The nose: An underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect 1998; 40(Suppl):S3-S11.
105. Hill RL, Fisher AP, Ware RJ, Wilson S, Casewell MW. Mupirocin for the reduction of colonization of internal jugular cannulae - A randomized controlled trial. J Hosp Infect 1990; 15:311-21.
106. Sesso R, Barbosa D, Leme IL, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: Effect of mupirocin ointment. J Am Soc Nephrol 1998; 9:1085-92.
107. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 1995; 31:189-93.
108. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemlol 1996; 17:811-3.
109. Rao SP, Oreopoulos DG. Unusual complications of a polyurethane PD catheter. Perit Dial Int 1997; 17:410-2.
110. Riu S, Ruiz CG, Martinez-Vea A, Peralta C, Oliver JA. Spontaneous rupture of polyurethane peritoneal catheter: A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 1998; 13:1870-1.
111. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344:11-6.
112. Zinner SH, Denny-Brown BC, Braun P, Burke JP, Toala P, Kass EH. Risk of infection with intravenous indwelling catheters: Effect of application of antibiotic ointment. J Infect Dis 1969; 120:616-9.
113. Norden CW. Application of antibiotic ointment to the site of venous catheterization - A controlled trial. J Infect Dis 1969; 120:611-5.
114. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981; 70:739-44.
115. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18:1269-78.
116. Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43:2200-4.
117. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8:1591-7.
118. Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995; 127:147-51.
119. Raad II, Buzaid A, Rhyne J, et al. Minocycline and ethylene-diaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997; 25:149-51.
120. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994; 271:1014-6.
121. Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter-related thrombosis in intensive care patients: Incidence, risk factors, and relationship with catheter-related sepsis. Chest 1998; 114:207-13.
122. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: A meta-analysis of randomized controlled trials. Chest 1998; 113:165-71.
123. Mermel LA, Stolz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis 1993; 167:920-4.
124. Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 2000; 26:967-72.
125. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: A randomized prospective trial. Ann Intern Med 1990; 112:423-8.
126. Boraks P, Seale J, Price J, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998; 101:483-6.
127. Collin J, Collin C. Infusion thrombophlebitis. Lancet 1975; 2:458.
128. Lai KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. Am J Infect Control 1998; 26:66-70.
129. Fontaine PJ. Performance of a new softening expanding midline catheter in home intravenous therapy patients. J Intraven Nurs 1991; 14:91-9.
130. Harwood IR, Greene LM, Kozakowski-Koch JA, Rasor JS. New peripherally inserted midline catheter: A better alternative for intravenous antibiotic therapy in patients with cystic fibrosis. Pediatr Pulmonol 1992; 12:233-9.
131. Mermel LA, Parenteau S, Tow SM. The risk of midline catheterization in hospitalized patients. A prospective study. Ann Intern Med 1995; 123:841-4.
132. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: Prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990; 18:1073-9.
133. Uldall PR, Merchant N, Woods F, Yarworski U, Vas S. Changing subclavian haemodialysis cannulas to reduce infection. Lancet 1981; 1:1373.
134. Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: A systematic review of the literature. Crit Care Med 1997; 25:1417-24.
135. Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992; 327:1062-8.
136. Robinson D, Suhocki P, Schwab SJ. Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 1998; 53:1792-4.
137. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999; 10:1045-9.
138. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34:1114-24.
139. Duszak R Jr., Haskal ZJ, Thomas-Hawkins C, et al. Replacement of failing tunneled hemodialysis catheters through pre-existing subcutaneous tunnels: A comparison of catheter function and infection rates for de novo placements and over-the-wire exchanges. J Vasc Interv Radiol 1998; 9:321-7.
140. Jaar BG, Hermann JA, Furth SL, Briggs W, Powe NR. Septicemia in diabetic hemodialysis patients: Comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients. Am J Kidney Dis 2000; 35:282-92.
141. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 1999; 55:1081-90.
142. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9:869-76.
143. Tokars JI, Miller ER, Alter MJ, et al. National surveillance of dialysis-associated diseases in the United States, 1997. Semin Dial 2000; 13:75-85.
144. Foundation NK. III. NKF-K/DOQI Clinical practice guidelines for vascular access: Update 2000. Am J Kidney Dis 2001; 37(Suppl):S137-S81.
145. Mermel LA. Intravascular catheters impregnated with benzalkonium chloride. J Antimicrob Chemother 1993; 32:905-6.
146. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management. Crit Care Med 1994; 22:1729-37.
147. Raad II, Umphrey J, Khan A, Truett LJ, Bodey GP. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect 1993; 23:17-26.
148. Cohen Y, Fosse JP, Karoubi P, et al. The " hands-off" catheter and the prevention of systemic infections associated with pulmonary artery catheter: A prospective study. Am J Respir Crit Care Med 1998; 157:284-7.
149. Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985; 6:367-70.
150. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals: 72 Hours is safe and cost-effective. JAMA 1987; 258:1777-81.
151. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987; 8:113-6.
152. Hanna HA, Raad II. Blood products: A significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 2001; 22:165-6.
153. Raad II, Hanna HA, Awad A, et al. Optimal frequency of changing intravenous administration sets: Is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol 2001; 22:136-9.
154. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20:1119-24.
155. Avila-Figueroa C, Goldmann DA, Richardson DK, Gray JE, Ferrari A, Freeman J. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J 1998; 17:10-7.
156. Crocker KS, Noga R, Filibeck DJ, Krey SH, Markovic M, Steffee WP. Microbial growth comparisons of five commercial parenteral lipid emulsions. JPEN J Parenter Enteral Nutr 1984; 8:391-5.
157. Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol 1984; 19:17-20.
158. Melly MA, Meng HC, Schaffner W. Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg 1975; 110:1479-81.
159. Inoue Y, Nezu R, Matsuda H, et al. Prevention of catheter-related sepsis during parenteral nutrition: Effect of a new connection device. JPEN J Parenter Enteral Nutr 1992; 16:581-5.
160. Arduino MJ, Bland LA, Danzig LE, McAllister SK, Aguero SM. Microbiologic evaluation of needleless and needle-access devices. Am J Infect Control 1997; 25:377-80.
161. Brown JD, Moss HA, Elliott TS. The potential for catheter microbial contamination from a needleless connector. J Hosp Infect 1997; 36:181-9.
162. Cookson ST, Ihrig M, O'Mara EM, et al. Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 1998; 19:23-7.
163. Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999; 179:442-8.
164. Luebke MA, Arduino MJ, Duda DL, et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control 1998; 26:437-41.
165. McDonald LC, Banerjee SN, Jarvis WR. Line-associated bloodstream infections in pediatric intensive-care-unit patients associated with a needleless device and intermittent intravenous therapy. Infect Control Hosp Epidemiol 1998; 19:772-7.
166. Mendelson MH, Short LJ, Schechter CB, et al. Study of a needleless intermittent intravenous-access system for peripheral infusions: Analysis of staff, patient, and institutional outcomes. Infect Control Hosp Epidemiol 1998; 19:401-6.
167. Seymour VM, Dhallu TS, Moss HA, Tebbs SE, Elliot TS. A prospective clinical study to investigate the microbial contamination of a needleless connector. J Hosp Infect 2000; 45:165-8.
168. Longfield RN, Smith LP, Longfield JN, Coberly J, Cruess D. Multiple-dose vials: Persistence of bacterial contaminants and infection control implications. Infect Control 1985; 6:194-9.
169. Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control 2001; 29:312-5.
170. Grohskopf LA, Roth VR, Feikin DR, et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 2001; 344:1491-7.
171. CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from April 1995-April 2000, issued June 2000. Am J Infect Control 2000; 28:429-35.
172. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States: National Nosocomial Infections Surveillance System. Pediatrics 1999; 103:e39.
173. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27:887-92.
174. Garland JS, Dunne WM Jr., Havens P, et al. Peripheral intravenous catheter complications in critically ill children: A prospective study. Pediatrics 1992; 89:1145-50.
175. Garland JS, Nelson DB, Cheah TE, Hennes HH, Johnson TM. Infectious complications during peripheral intravenous therapy with Teflon catheters: A prospective study. Pediatr Infect Dis J 1987; 6:918-21.
176. Furfaro S, Gauthier M, Lacroix J, Nadeau D, Lafleur L, Mathews S. Arterial catheter-related infections in children: A 1-year cohort analysis. Am J Dis Child 1991; 145:1037-43.
177. Krauss AN, Albert RF, Kannan MM. Contamination of umbilical catheters in the newborn infant. J Pediatr 1970; 77:965-9.
178. Landers S, Moise AA, Fraley JK, Smith EO, Baker CJ. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child 1991; 145:675-80.
179. Balagtas RC, Bell CE, Edwards LD, Levin S. Risk of local and systemic infections associated with umbilical vein catheterization: A prospective study in 86 newborn patients. Pediatrics 1971; 48:359-67.
180. Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous central venous catheterization in a pediatric intensive care unit: A survival analysis of complications. Crit Care Med 1989; 17:984-8.
181. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107:1431-6.
182. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: Do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA 1999; 282:867-74.
183. Conly JM, Hill S, Ross J, Lertzman J, Louie TJ. Handwashing practices in an intensive care unit: The effects of an educational program and its relationship to infection rates. Am J Infect Control 1989; 17:330-9.
184. East SA. Planning, implementation, and evaluation of a successful hospital-based peripherally inserted central catheter program. J Intraven Nurs 1994; 17:189-92.
185. Kyle KS, Myers JS. Peripherally inserted central catheters: Development of a hospital-based program. J Intraven Nurs 1990; 13:287-90.
186. BeVier PA, Rice CE. Initiating a pediatric peripherally inserted central catheter and midline catheter program. J Intraven Nurs 1994; 17:201-5.
187. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications: A prospective controlled study. Arch Intern Med 1984; 144:1191-4.
188. Wenzel RP, Wentzel RP. The development of academic programs for quality assessment. Arch Intern Med 1991; 151:653-4.
189. Robert J, Fridkin SK, Blumberg HM, et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000; 21:12-7.
190. Vicca AF. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 1999; 43:109-13.
191. White MC, Ragland KE. Surveillance of intravenous catheter-related infections among home care clients. Am J Infect Control 1994; 22:231-5.
192. Lorenzen AN, Itkin DJ. Surveillance of infection in home care. Am J Infect Control 1992; 20:326-9.
193. White MC. Infections and infection risks in home care settings. Infect Control Hosp Epidemiol 1992; 13:535-9.
194. Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: The role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995; 20:593-7.
195. Widmer AF, Nettleman M, Flint K, Wenzel RP. The clinical impact of culturing central venous catheters: A prospective study. Arch Intern Med 1992; 152:1299-302.
196. Boyce JM, Farr BM, Jarvis WR, et al. Guideline for hand hygiene in the healthcare setting. Am J Infect Control 2002 (in press).
197. Bischoff WE, Reynolds TM, Sessler CN, Edmond MB, Wenzel RP. Handwashing compliance by health care workers: The impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med 2000; 160:1017-21.
198. Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999; 159:821-6.
199. Simmons B, Bryant J, Neiman K, Spencer L, Arheart K. The role of handwashing in prevention of endemic intensive care unit infections. Infect Control Hosp Epidemiol 1990; 11:589-94.
200. Boyce JM, Kelliher S, Vallande N. Skin irritation and dryness associated with two hand-hygiene regimens: Soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol 2000; 21:442-8.
201. Capdevila JA. Catheter-related infection: An update on diagnosis, treatment, and prevention. Int J Infect Dis 1998; 2:230-6.
202. Abi-Said D, Raad II, Umphrey J, Gonzalez V, Richardson D, Marts K, Hohn D. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol 1999; 20:101-5.
203. CDC. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood-borne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 1988; 37:377-82, 388.
204. Povoski SP. A prospective analysis of the cephalic vein cutdown approach for chronic indwelling central venous access in 100 consecutive cancer patients. Ann Surg Oncol 2000; 7:496-502.
205. Arrighi DA, Farnell MB, Mucha P Jr., Iistrup DM, Anderson DL. Prospective, randomized trial of rapid venous access for patients in hypovolemic shock. Ann Emerg Med 1989; 18:927-30.
206. Ahmed Z, Mohyuddin Z. Complications associated with different insertion techniques for Hickman catheters. Postgrad Med J 1998; 74:104-7.
207. Little JR, Murray PR, Traynor PS, Spitznagel E. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: Effects on rates of blood culture contamination. Am J Med 1999; 107:119-25.
208. Mimoz O, Pieroni L, Lawrence C, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996; 24:1818-23.
209. Maki DG, McCormack KN. Defatting catheter insertion sites in total parenteral nutrition is of no value as an infection control measure. Controlled clinical trial. Am J Med 1987; 83:833-40.
210. Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1999; 20:618-20.
211. Rasero L, Degl'Innocenti M, Mocali M, et al. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: Results of a randomized, multicenter study. Haematologica 2000; 85:275-9.
212. Madeo M, Martin CR, Turner C, Kirkby V, Thompson DR. A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive Crit Care Nurs 1998; 14:187-91.
213. Flowers RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: A randomized, controlled trial. JAMA 1989; 261:878-83.
214. Robbins J, Cromwell P, Korones DN. Swimming and central venous catheter-related infections in the child with cancer. J Pediatr Oncol Nurs 1999; 16:51-6.
215. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer 1995; 75:1367-75.
216. Goetz AM, Miller J, Wagener MM, Muder RR. Complications related to intravenous midline catheter usage: A 2-year study. J Intraven Nurs 1998; 21:76-80.
217. Martin C, Viviand X, Saux P, Gouin F. Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med 1999; 27:2626-9.
218. Robinson JF, Robinson WA, Cohn A, Garg K, Armstrong JD. Perforation of the great vessels during central venous line placement. Arch Intern Med 1995; 155:1225-8.
219. Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter. Ann Intern Med 1992; 116:737-8.
220. Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intravenous catheter use: Internal medicine house staff participate in a successful quality improvement project. Arch Intern Med 1994; 154:1829-32.
221. Thomas F, Burke JP, Parker J, et al. The risk of infection related to radial vs femoral sites for arterial catheterization. Crit Care Med 1983; 11:807-12.
222. Nelson DB, Garland JS. The natural history of Teflon catheter-associated phlebitis in children. Am J Dis Child 1987; 141:1090-2.
223. Shimandle RB, Johnson D, Baker M, Stotland N, Karrison T, Arnow PM. Safety of peripheral intravenous catheters in children. Infect Control Hosp Epidemiol 1999; 20:736-40.
224. O'Grady NP, Barie PS, Bartlett J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med 1998; 26:392-408.
225. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-72.
226. Mershon J, Nogami W, Williams JM, Yoder C, Eitzen HE, Lemons JA. Bacterial/fungal growth in a combined parenteral nutrition solution. JPEN J Parenter Enteral Nutr 1986; 10:498-502.
227. Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. JPEN J Parenter Enteral Nutr 1986; 10:494-7.
228. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis 1975; 131:267-72.
229. Didier ME, Fischer S, Maki DG. Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: Growth properties of microbial pathogens at room temperature. JPEN J Parenter Enteral Nutr 1998; 22:291-6.
230. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333:147-54.
231. Roth VR, Arduino MJ, Nobiletti J, et al. Transfusion-related sepsis due to Serratia liquefaciens in the United States. Transfusion 2000; 40:931-5.
232. Blajchman MA. Reducing the risk of bacterial contamination of cellular blood components. Dev Biol Stand 2000; 102:183-93.
233. Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993; 33:228-33.
234. Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994; 7:290-302.
235. Plott RT, Wagner RF Jr., Tyring SK. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol 1990; 126:1441-4.
236. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993; 31:475-9.
237. ASPH Council on Professional Affairs. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health Syst Pharm 2000; 57:1150-69.
238. Herruzo-Cabrera R, Garcia-Caballero J, Vera-Cortes ML, et al. Growth of microorganisms in parenteral nutrient solutions. Am J Hosp Pharm 1984; 41:1178-80.
239. Green KA, Shouldachi B, Schoer K, Moro D, Blend R, McGeer A. Gadolinium-based MR contrast media: Potential for growth of microbial contaminants when single vials are used for multiple patients. AJR Am J Roentgenol 1995; 165:669-71.
240. Arrington ME, Gabbert KC, Mazgaj PW, Wolf MT. Multidose vial contamination in anesthesia. Aana J 1990; 58:462-6.
241. Falchuk KH, Peterson L, McNeil BJ. Microparticulate-induced phlebitis: Its prevention by in-line filtration. N Engl J Med 1985; 312:78-82.
242. Cohran J, Larson E, Roach H, Blane C, Pierce P. Effect of intravascular surveillance and education program on rates of nosocomial bloodstream infections. Heart Lung 1996; 25:161-4.
243. Netto dos Santos KR, de Souza Fonseca L, Gontijo Filho PP. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol 1996; 17:813-6.
244. Ryder MA. Peripheral access options. Surg Oncol Clin N Am 1995; 4:395-427.
245. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973; 79:867-87.
246. Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983; 118:839-51.
247. Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am J Infect Control 1997; 25:112-6.
248. Khuri-Bulos NA, Shennak M, Agabi S, et al. Nosocomial infections in the intensive care units at a university hospital in a developing country: Comparison with National Nosocomial Infections Surveillance intensive care unit rates. Am J Infect Control 1999; 27:547-52.
249. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155:1177-84.
250. CDC. Monitoring hospital-acquired infections to promote patient safety - United States, 1990-1999. MMWR Morb Mortal Wkly Rep 2000; 49:149-53.
251. Clark-Christoff N, Watters VA, Sparks W, Snyder P, Grant JP. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. JPEN J Parenter Enteral Nutr 1992; 16:403-7.
252. Early TF, Gregory RT, Wheeler JR, Snyder SO Jr., Gayle RG. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J 1990; 83:34-6.
253. Hilton E, Haslett TM, Borenstein MT, Tucci V, Isenberg HD, Singer C. Central catheter infections: Single- versus triple-lumen catheters: Influence of guide wires on infection rates when used for replacement of catheters. Am J Med 1988; 84:667-72.
254. Yeung C, May J, Hughes R. Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol 1988; 9:154-8.
255. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: A continuous quality improvement project. Chest 1999; 115:1632-40.
256. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119:1168-74.
257. Pegues D, Axelrod P, McClarren C, et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992; 49:156-62.
258. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 1990; 16:211-5.
259. Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterization vein stenosis in haemodialysis: Comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 1991; 6:722-4.
260. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990; 54:154-61.
261. Barrett N, Spencer S, McIvor J, Brown EA. Subclavian stenosis: A major complication of subclavian dialysis catheters. Nephrol Dial Transplant 1988; 3:423-5.
262. Trerotola SO, Kuhn-Fulton J, Johnson MS, Shah H, Ambrosius WT, Kneebone PH. Tunneled infusion catheters: Increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access. Radiology 2000; 217:89-93.
263. Macdonald S, Watt AJ, McNally D, Edwards RD, Moss JG. Comparison of technical success and outcome of tunneled catheters inserted via the jugular and subclavian approaches. J Vasc Interv Radiol 2000; 11:225-31.
264. Widmer AF. Management of catheter-related bacteremia and fungemia in patients on total parenteral nutrition. Nutrition 1997; 13(Suppl):18S-25S.
265. Powell C, Kudsk KA, Kulich PA, Mandelbaum JA, Fabri PJ. Effect of frequent guidewire changes on triple-lumen catheter sepsis. JPEN J Parenter Enteral Nutr 1988; 12:462-4.
266. Snydman DR, Murray SA, Kornfeld SJ, Majka JA, Ellis CA. Total parenteral nutrition-related infections: Prospective epidemiologic study using semiquantitative methods. Am J Med 1982; 73:695-9.
267. Easom A. Prophylactic antibiotic lock therapy for hemodialysis catheters. Nephrol Nurs J 2000; 27:75.
268. Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ. Antibiotic-heparin lock: In vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 2000; 20:394-9.
269. Donowitz LG, Marsik FJ, Hoyt JW, Wenzel RP. Serratia marcescens bacteremia from contaminated pressure transducers. JAMA 1979; 242:1749-51.
270. Luskin RL, Weinstein RA, Nathan C, Chamberlin WH, Kabins SA. Extended use of disposable pressure transducers: A bacteriologic evaluation. JAMA 1986; 255:916-20.
271. Maki DG, Hassemer CA. Endemic rate of fluid contamination and related septicemia in arterial pressure monitoring. Am J Med 1981; 70:733-8.
272. Mermel LA, Maki DG. Epidemic bloodstream infections from hemodynamic pressure monitoring: Signs of the times. Infect Control Hosp Epidemiol 1989; 10:47-53.
273. Tenold R, Priano L, Kim K, Rourke B, Marrone T. Infection potential of nondisposable pressure transducers prepared prior to use. Crit Care Med 1987; 15:582-3.
274. Leroy O, Billiau V, Beuscart C, et al. Nosocomial infections associated with long-term radial artery cannulation. Intensive Care Med 1989; 15:241-6.
275. Fisher MC, Long SS, Roberts EM, Dunn JM, Balsara RK. Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA 1981; 246:1571-4.
276. Stamm WE, Colella JJ, Anderson RL, Dixon RE. Indwelling arterial catheters as a source of nosocomial bacteremia: An outbreak caused by Flavobacterium Species. N Engl J Med 1975; 292:1099-102.
277. Weinstein RA, Emori TG, Anderson RL, Stamm WE. Pressure transducers as a source of bacteremia after open heart surgery: Report of an outbreak and guidelines for prevention. Chest 1976; 69:338-44.
278. Shinozaki T, Deane RS, Mazuzan JE Jr, Hamel AJ, Hazelton D. Bacterial contamination of arterial lines: A prospective study. JAMA 1983; 249:223-5.
279. Solomon SL, Alexander H, Eley JW, et al. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis 1986; 5:680-5.
280. Weems JJ Jr., Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987; 25:1029-32.
281. Beck-Sague CM, Jarvis WR, Brook JH, et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol 1990; 132:723-33.
282. Villarino ME, Jarvis WR, O'Hara C, Bresnahan J, Clark N. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol 1989; 27:2433-6.
283. Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health 1999; 35:460-5.
284. Cronin WA, Germanson TP, Donowitz LG. Intravascular catheter colonization and related bloodstream infection in critically ill neonates. Infect Control Hosp Epidemiol 1990; 11:301-8.
285. Miller KL, Coen PE, White WJ, Hurst WJ, Achey BE, Lang CM. Effectiveness of skin absorption of tincture of I in blocking radioiodine from the human thyroid gland. Health Phys 1989; 56:911-4.
286. Ankola PA, Atakent YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol 1993; 10:229-32.
287. Horgan MJ, Bartoletti A, Polansky S, Peters JC, Manning TJ, Lamont BM. Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications. J Pediatr 1987; 111:774-8.
288. David RJ, Merten DF, Anderson JC, Gross S. Prevention of umbilical artery catheter clots with heparinized infusates. Dev Pharmacol Ther 1981; 2:117-26.
289. Fletcher MA, Brown DR, Landers S, Seguin J. Umbilical arterial catheter use: Report of an audit conducted by the Study Group for Complications of Perinatal Care. Am J Perinatol 1994; 11:94-9.
290. Seguin J, Fletcher MA, Landers S, Brown D, Macpherson T. Umbilical venous catheterizations: Audit by the Study Group for Complications of Perinatal Care. Am J Perinatol 1994; 11:67-70.
291. Loisel DB, Smith MM, MacDonald MG, Martin GR. Intravenous access in newborn infants: Impact of extended umbilical venous catheter use on requirement for peripheral venous lines. J Perinatol 1996; 16:461-6.
292. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
293. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988 [erratum]. Am J Infect Control 1988; 16:177.